Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes [RNA-seq]

ABSTRACT: Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes [RNA-seq]

PROVIDER: PRJNA860369 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR20325022_1.fastq.gz	Fastqsanger.gz
	SRR20325022_2.fastq.gz	Fastqsanger.gz
	SRR20325023_1.fastq.gz	Fastqsanger.gz
	SRR20325023_2.fastq.gz	Fastqsanger.gz
	SRR20325024_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes.

Project description:Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes.

| PRJNA860364 | ENA

Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes [WGBS]

Project description:Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes [WGBS]

| PRJNA860368 | ENA

Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes [WGBS]

Project description:Diabetes-resistant and diabetes-prone female New Zealand Obese mice were classified based on liver fat content and early blood glucose concentrations at 10 weeks of age before the onset of T2D. By using transcriptome and DNA methylome analysis of liver samples, we identified early epigenetic alteration in mice and humans which could serve as putative epigenetic biomarkers

2023-07-17 | GSE208628 | GEO

Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes [RNA-seq]

2023-07-17 | GSE208627 | GEO

Longitudinal DNA methylation differences precede type 1 diabetes

Project description:DNA methylation may be involved in development of type 1 diabetes (T1D), but previous epigenome-wide association studies were conducted among cases with clinically diagnosed diabetes. Using multiple pre-disease peripheral blood samples on the Illumina 450K and EPIC platforms, we investigated longitudinal methylation differences between 87 T1D cases and 87 controls from the prospective Diabetes Autoimmunity Study in the Young (DAISY) cohort. Change in methylation with age differed between cases and controls in 10 regions. Average longitudinal methylation differed between cases and controls at two genomic positions and 28 regions. Some methylation differences were detectable and consistent as early as birth, including before and after the onset of preclinical islet autoimmunity. Results map to transcription factors, other protein coding genes, and non-coding regions of the genome with regulatory potential. The identification of methylation differences that predate islet autoimmunity and clinical diagnosis may suggest a role for epigenetics in T1D pathogenesis.

2020-03-09 | GSE142512 | GEO

Longitudinal DNA methylation differences precede type 1 diabetes

Project description:Longitudinal DNA methylation differences precede type 1 diabetes

| PRJNA597238 | ENA

Genome wide methylation of cord blood from gestational diabetes mellitus

Project description:Genome wide DNA methylation profiling of cord blood cells obtained from gestational diabetes mellitus (GDM) pregnancies. The Illumina EPIC methylation beadchip array was used to obtain DNA methylation profiles across approximately 850,000 CpG dinucleotide methylation loci in DNA isolated from cord blood. Samples include 165 GDM subjects.

2021-06-23 | GSE122086 | GEO

Illumina methylation EPIC array of human blood from patients with type 2 diabetes

Project description:To explore the possibility that DNAm-derived biological age is associated with mortality independently of common risk factors in subjects with type 2 diabetes (T2D), we leveraged a well-characterized cohort of individuals with T2D and followed-up for 16.8 years to create two groups, one of deceased individuals and the other of survived patients, fully matched for common risk factors. We performed a genome wide DNAm analysis of peripheral blood leukocytes to explore differentially methylated genes related to death in T2D, test the ability of a chosen set of existing tools estimating biological aging from DNAm to predict mortality, and assess the differences between deceased and survived diabetic patients in DNAm-inferred levels of selected inflammatory proteins and in predicted blood cell counts with a known pathophysiological role in T2D.

2024-07-05 | E-MTAB-14228 | biostudies-arrayexpress

Methylation arrays (MethylationEPIC) of whole blood of individuals with type 1 diabetes

Project description:Type 1 diabetes (1a) diabetes is an autoimmune disease in which both environmental and genetic factors play a role. Epigenetic marks such as DNA methylation, being molecular links between the environment and the genome function, are sound candidates for the explanation of part of the aetiology and mechanisms of the disease. Here, the methylomes of the whole blood of 18 adult individuals with T1D were profiled using Illumina's MethylationEPIC array technology.

2020-12-22 | E-MTAB-8694 | biostudies-arrayexpress

Genome wide methylation of cord blood from gestational diabetes mellitus

Project description:Genome wide methylation of cord blood from gestational diabetes mellitus

| PRJNA503485 | ENA